GlobeNewswire
Contact Us
Register
Sign In
English
Français
About this file
VUMERITY™ (diroximel fumarate) Approved for Relapsing Multiple Sclerosis
Message from Biogen CEO, Michel Vounatsos
Biogen Inc.
Format
YouTube
Source
Biogen Inc.
ASSOCIATED PRESS RELEASE
Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis
Published
October 30, 2019 07:30 ET